share_log

信達生物：(1)建議根據2020年受限制股份計劃向董事授出受限制股份、(2)建議採納2024年股份計劃及(3)股東特別大會通告

INNOVENT BIO: (1) PROPOSED GRANTS OF RESTRICTED SHARES TO DIRECTORSUNDER THE 2020 RS PLAN,(2) PROPOSED ADOPTION OF THE 2024 SHARE SCHEME, AND(3) NOTICE OF EXTRAORDINARY GENERAL MEETING

HKEX ·  Jun 4 17:29
Summary by Futu AI
信達生物製藥（INNOVENT BIOLOGICS, INC.）將於2024年6月21日舉行股東特別大會，以審議多項議案，包括根據2020年受限制股份計劃向董事授出受限制股份，並建議採納2024年股份計劃。股東特別大會將於中國蘇州工業園區信達生物行政大樓5層耶魯會議室召開。會議將審議向俞德超博士、奚浩先生、Charles Leland Cooney博士、許懿尹女士、陳凱先博士、Gary Zieziula先生及陳樹云先生等董事授出的受限制股份。此外，將討論採納2024年股份計劃，該計劃旨在透過為合資格參與者提供獲得公司專有權益的機會，使其利益與公司及股東利益保持一致，並鼓勵他們為公司的長期發展、業績及盈利作出貢獻。
信達生物製藥（INNOVENT BIOLOGICS, INC.）將於2024年6月21日舉行股東特別大會，以審議多項議案，包括根據2020年受限制股份計劃向董事授出受限制股份，並建議採納2024年股份計劃。股東特別大會將於中國蘇州工業園區信達生物行政大樓5層耶魯會議室召開。會議將審議向俞德超博士、奚浩先生、Charles Leland Cooney博士、許懿尹女士、陳凱先博士、Gary Zieziula先生及陳樹云先生等董事授出的受限制股份。此外，將討論採納2024年股份計劃，該計劃旨在透過為合資格參與者提供獲得公司專有權益的機會，使其利益與公司及股東利益保持一致，並鼓勵他們為公司的長期發展、業績及盈利作出貢獻。
Innovent Biologics, Inc. will hold a special shareholder meeting on June 21, 2024 to review multiple proposals, including the restricted share grants to directors pursuant to the 2020 Restricted Share Plan and the proposed 2024 Share Plan. The shareholder meeting will be held at the Yale Conference Room, 5th Floor, Innovent Biologics Administration Building in Suzhou Industrial Park, China. The meeting will review the restricted share grants to directors, including Dr. Dechao Yu, Mr. Hao Xi, Dr. Charles Leland Cooney, Ms. Yiyin Xu, Dr. Kai Chen, Mr. Gary Zieziula, and Mr. Shuyun Chen. The meeting will also discuss the proposed 2024 Share Plan, which aims to provide eligible participants with the opportunity to obtain proprietary interests in the company, aligning their interests with the company and shareholders, and encouraging them to contribute to the company's long-term development, performance, and profits.
Innovent Biologics, Inc. will hold a special shareholder meeting on June 21, 2024 to review multiple proposals, including the restricted share grants to directors pursuant to the 2020 Restricted Share Plan and the proposed 2024 Share Plan. The shareholder meeting will be held at the Yale Conference Room, 5th Floor, Innovent Biologics Administration Building in Suzhou Industrial Park, China. The meeting will review the restricted share grants to directors, including Dr. Dechao Yu, Mr. Hao Xi, Dr. Charles Leland Cooney, Ms. Yiyin Xu, Dr. Kai Chen, Mr. Gary Zieziula, and Mr. Shuyun Chen. The meeting will also discuss the proposed 2024 Share Plan, which aims to provide eligible participants with the opportunity to obtain proprietary interests in the company, aligning their interests with the company and shareholders, and encouraging them to contribute to the company's long-term development, performance, and profits.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.